Three common medicines classified as carcinogenic by IARC; experts urge patients not to stop treatment | Explained
The WHO's cancer research agency, IARC, has classified three essential medicines—hydrochlorothiazide, voriconazole, and tacrolimus—as carcinogenic hazards. Experts emphasize that this classification identifies a potential hazard rather than a direct risk, and patients should not discontinue treatment without medical advice.
The story so far : Three widely prescribed medicines used to treat high blood pressure, life-threatening fungal infections and organ transplant rejection have been classified as “carcinogenic to humans” (Group 1) by the International Agency for Research on Cancer (IARC), the World Health Organisation’s specialised cancer research agency.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in